The natural history of hepatitis B virus infection;HISTOIRE NATURELLE DE L'INFECTION VIRALE B

Medecine Therapeutique

Volumn 4, Issue 1, 1998, Pages 21-30

  Zylberberg, Hervé ^a   Pol, Stanislas ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERFERON; VIRUS DNA;

ACUTE HEPATITIS; CHRONIC HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS DELTA VIRUS; HUMAN; IMMUNE DEFICIENCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MIXED INFECTION; MORBIDITY; MORTALITY; PREVALENCE; REVIEW; SEROCONVERSION; VIRUS GENOME; VIRUS INFECTION; VIRUS MUTANT; VIRUS REACTIVATION; VIRUS TRANSMISSION;

EID: 0031912984     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Wright T.L., Lau J.Y.N. 1993. Clinical aspects of hepatitis B virus infection. Lancet 342 : 1340.
2. Bréchot C., et al. 1981. Detection of hepatitis B virus DNA in liver and serum : a direct appraisal of the chronic carrier state. Lancet ii : 765-767.
3. McMahon B.J., et al. 1985. Acute hepatitis B virus infection : relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 : 599-603
4. Krugman S., Overby L.R., Mushahwar I.K., Ling C.M., Frösner G.G., Deinhardt F. 1979. Viral hepatitis type B : studies on natural history and prevention re-examined. N Engl J Med 300 : 101-106.
5. Saracco G., Macagno S., Rosina F., Caredda F., Antinori S., Rizzeto M. 1988. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiology and clinical survey. Ann Intern Med 108 : 380-383.
6. Bernau J., et al. 1986 Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6 : 648-651.
7. Horney J.T., Galambos J.T. 1977. The liver during and after fulminant hepatitis. Gastroenterology 73 : 639-645.
8. Tassopoulos N.C., Papaevangelou G.J., Sjogren M.H., Roumeliotou-Karayannis A., Gerin J.L., Purcell R.H. 1987. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 92 : 1844-1850
9. Almarri A., Batchelor J.R. 1994 HLA and hepatitis B infection. Lancet 344 : 1194-1195.
10. Ferrari C., et al. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145 : 3442-3449.
11. Penna A., et al 1997. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 25 : 1022-1026.
12. Bortollotti F., et al. 1990. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 99 : 805-810.
13. Zylberberg H., Pol S. 1996. Doit-on surveiller les « porteurs sains » de l'antigène HBs ? Gastroenterol Clin Biol 20 : 727-729
14. Hoofnagle J.H., Shafritz D.A., Popper H. 1987. Chronic type B hepatitis and the « healthy » HBsAg carrier state. Hepatology 7 : 758-763
15. Gerken G., et al. 1991. Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S and S-encoded viral surface antigens. Hepatology 13 : 158-166.
16. Villeneuve J.P., Desrochers M., Infante-Rivard L., Willems B., Raymond G., Bourcier M. 1994. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 106 : 1000-1005.
17. De Franchis R., et al. 1993. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118 : 191-194.
18. Sakuma K., et al. 1988. Relative risks of death due to liver disease among Japanese male adults having various statutes for hepatitis B s and e antigen/antibody in serum : a prospective study. Hepatology 8 : 1642-1646.
19. Chu C.M., Karayiannis P., Fowler M.J.F., Monjardino J., Liaw Y.F., Thomas H.C. 1985. Natural history of chronic hepatitis B virus infection in Taiwan : studies of hepatitis B virus DNA in serum. Hepatology 5 : 431-434.
20. Realdi G., et al. 1980. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 79 : 195-199.
21. Liaw Y.F., Chen J.J., Chen T.J. 1990. Acute exacerbation in patients with liver cirrhosis : a clnicopathological study. Liver 10 : 177-184.
22. Weissberg J.I., et al. 1984. Survival in chronic hepatitis B. Ann Intern Med 101 : 613-616.
23. Liaw Y.F., Tai D.I., Chu C.M., Chen T.J. 1988. The development of cirrhosis in patients with chronic type B hepatitis : a prospective study. Hepatology 8 : 493-496.
24. Fattovitch G., et al. 1991. Natural history and prognostic factors for chronic hepatitis B. Gut 32 : 294-298.
25. Pol S., et al. 1990. Chronic hepatitis in kidney allograft recipients. Lancet 335 : 878-880.
26. Liaw Y.F., Lin D.Y., Chen T.J., Chu C.M. 1989. Natural course after the development of cirrhosis in patients with chronic type B hepatitis : a prospective study. Liver 9 : 235-241.
27. Beasley R.P., Lin C.C., Hwang L.Y., Chien C.S. 1981. Hepatocellular carcinoma and hepatitis B virus : a prospective study of 22 707 men in Taiwan. Lancet ii : 1129-1133.
28. Paterlini P., et al. 1990. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 323 : 80-85.
29. Bréchot C. 1987. Hepatitis B virus (HBV) and hepatocellular carcinoma : HBV DNA status and its implications. J Hepatol 312 : 270-276
30. Nalpas B., Bréchot C. 1992. The role of hepatitis viruses in the genesis of hepatocellular carcinoma in alcoholic cirrhotics. In : Watson R.R., ed. Alcool and cancer. London CRC Press, 91-119.
31. De Jongh F.E., Janssen H.L.A., De Man R A., Hop W C J, Schalm S.W., Van Blankenstein M. 1992 Survival and prognostic indicators in hepatitis B surface antigen positive cirrhosis of the liver. Gastroenterology 103 . 1630-1635.
32. Global Adversory Group. 1993. Plan of action for hepatitis B control. 16th meeting. Washington D.C. :OMS, 1-14.
33. Lok A.S.F., Lai C.L., Wu P.C., Leung E.K.Y., Lam T.S. 1987. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92 : 1839-1843
34. Liaw Y.F., Pao C.C., Chu C.M., Sheen I.S., Huang M.J. 1987. Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis. Hepatology 7 : 1-3.
35. Hoofnagle J.H , Dusheiko G.M., Seef L.B., Jones E.A., Waggoner J.G., Bales Z.B. 1981. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 94 : 744-748.
36. Sheen I.S., Liaw Y.F., Tai D.I., Chu C.M. 1985. Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis. Gastroenterology 89 : 732-735.
37. Liaw Y.F., Chu C.M., Su I.J., Huang M.J., Lin D.Y., Chang-Chien C.S. 1983. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology 84 : 216-219.
38. Loriot M.A., et al. 1992. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 15 : 32-36.
39. Niederau K., et al. 1996. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334 : 1422-1427.
40. Liaw Y.F., Sheen I.S., Chen T.J., Chu C.M., Pao C.C. 1991. Incidence determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection. Hepatology 13 : 627-631.
41. Fong T.L., Di Bisceglie A.M., Gerber M.A., Waggoner J.G., Hoofnagle J.H 1993. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18 : 1313-1318.
42. Adachi H., Kaneko S., Matsushita E., Inagaki Y., Unoura M., Kobayashi K. 1992. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 16 : 1334-1337.
43. Levy P., Marcellin P., Martinot-Peignoux M., Degott C., Nataf J , Benhamou J.P. 1990. Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology 12 : 570-574.
44. Davis G.L., Hoofnagle J.H., Waggoner J.G. 1984. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86 : 230-235.
45. Fattovitch G., et al. 1990. Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis. Liver 10 : 141-146
46. Gayno S., et al. 1992. Detection of serum HBV-DNA by polymerase chain reaction in patients before reactivation of chronic hepatitis B. J Hepatol 14 : 357-360.
47. Govindarajan S., Chin K.P., Redeker A.G., Peers R.L 1984. Fulminant B viral hepatitis : role of delta agent. Gastroenterology-86 : 1417-1420.
48. Smedile A., et al. 1981. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology 81 : 992-997
49. Fattovitch G., et al. 1987. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 155 : 931-935.
50. Fong T.L., Di Bisceglie M , Waggoner J.G., Banks S.M., Banks S.M., Hoofnagle J.H. 1991. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 14 : 64-67
51. Hoofnagle J.H., et al. 1982. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 96 : 447-449.
52. Lau J.Y.N., et al. 1992. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 102 . 956-962.
53. Fornairon S., Pol S , Legendre C., Carnot F., Bréchot C., Kreis H. 1996. The long term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 62 : 297-299.
54. Horvath J., Raffanti S.P. 1994. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 18 : 339-347.
55. Housset C., et al. 1992. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infection in 260 chronic carriers of hepatitis B virus. Hepatology 15 : 578-583.
56. Benhamou Y., et al. 1995. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 345 : 396-397.
57. Lok A.S.F., Liang R.H., Chiu E.K.W., Chan T.K., Todd D. 1991. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy : report of a prospective study. Gastroenterology 100 : 182-188.
58. Poterucha J.J., Wiesner R.H. 1997. Liver transplantation and hepatitis B. Ann Intern Med 126 : 805-807.
59. Giannoti F.A. 1973. Papular acrodermatis of childhood. An Australian antigen disease. Arch Dis Child 48 : 794-799.
60. McMahon B.J , Heyward W.L., Templin D.W., Clement D., Lanier A.P. 1989. Hepatitis B-associated polyarteritis nodosa in Alaskan eskimos : clinical and epidemiologic features and long term follow-up. Hepatology 9 : 97-101.
61. Lai K.N., et al. 1991. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324 : 1457-1463.
62. Bonino F., et al. 1986 Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 90 : 1268-1273.
63. Brunetto M.R., et al. 1989. Natural course and response to interferon of chronic hepatitis B accompagnied by antibody to hepatitis Be antigen Hepatology 10 : 198-202.
64. Brunetto M.R., Giarin M., Saracco G , Oliveri F., Calvo P., Capra G. 1993. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 105 : 845-850
65. Liang T.H., Hasegawa K., Rimon N., Wands J.R., Ben-Porath E. 1991. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324 : 1705-1709.
66. Carman W.F., et al. 1990 Vaccine-induced escape mutant of hepatitis B virus. Lancet 336 : 325-329
67. Chang M.H., et al. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336 : 1855-1859.
68. Dienstag J.L., Perillo R.P., Schiff E R., Bartholome M., Vicary C., Rubin M. 1995 A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333 : 1657-1661.